Insider Trading & Ownership - Leavitt Chase C.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Leavitt Chase C.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-04-12
Purchase		2023-04-14
06:00 am		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		25,000$0.29$7,250106,901
(Direct)		View
2022-01-27
Purchase		2022-01-31
4:00 pm		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		13,500$1.7244$23,28044,867
(Direct)		View
2021-06-11
Purchase		2021-06-15
6:00 pm		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		1,500$5.45$8,1751,500
(Direct)		View
2019-08-13
Purchase		2019-08-15
08:42 am		Lineage Cell Therapeutics Inc.LCTXLeavitt Chase C.
General Counsel/Secretary		5,000$1.02$5,100130,000
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-02-14
Option Award		2024-02-15
6:00 pm		N/A
2034-02-14		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		14,200$014,200
(Direct)		View
2024-01-03
Tax Withholding		2024-01-05
4:00 pm		N/A
N/A		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		11,838$0.496184,758
(Direct)		View
2023-10-02
Disposition		2023-10-04
5:01 pm		N/A
2031-04-29		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		359,269$0594,269
(Direct)		View
2023-10-02
Option Award		2023-10-04
5:01 pm		N/A
2031-04-29		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		594,269$0594,269
(Direct)		View
2023-07-03
Tax Withholding		2023-07-05
6:59 pm		N/A
N/A		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		10,305$0.3696,596
(Direct)		View
2023-02-21
Option Award		2023-02-23
8:01 pm		N/A
2033-02-21		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		210,000$0210,000
(Direct)		View
2023-01-03
Tax Withholding		2023-01-05
6:00 pm		N/A
N/A		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		6,091$1.0281,901
(Direct)		View
2022-07-28
Option Award		2022-08-01
6:22 pm		N/A
2032-07-28		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		71,875$0116,742
(Direct)		View
2022-01-20
Option Award		2022-01-24
4:00 pm		N/A
2032-01-20		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		55,519$055,519
(Direct)		View
2022-01-03
Option Award		2022-01-05
7:00 pm		N/A
N/A		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		29,867$031,367
(Direct)		View

Ownership		2021-05-27
6:06 pm		N/A
2031-04-12		Oncternal Therapeutics Inc.ONCTLeavitt Chase C.
General Counsel/Secretary		0$0300,000
(Direct)		View
2021-03-15
Option Award		2021-03-17
5:00 pm		N/A
2031-03-15		Lineage Cell Therapeutics Inc.LCTXLeavitt Chase C.
General Counsel/Secretary		699,100$0699,100
(Direct)		View
2020-03-17
Option Award		2020-03-19
5:00 pm		N/A
2030-03-17		Lineage Cell Therapeutics Inc.LCTXLeavitt Chase C.
General Counsel/Secretary		616,700$0616,700
(Direct)		View
2019-07-31
Option Award		2019-08-15
08:42 am		N/A
2029-07-30		Lineage Cell Therapeutics Inc.LCTXLeavitt Chase C.
General Counsel/Secretary		125,000$0130,000
(Direct)		View
2019-05-20
Option Award		2019-05-22
4:31 pm		N/A
2029-05-19		BIOTIME INCBTXLeavitt Chase C.
General Counsel/Secretary		300,000$0300,000
(Direct)		View